1. Home
  2. SRPT vs PAYO Comparison

SRPT vs PAYO Comparison

Compare SRPT & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • PAYO
  • Stock Information
  • Founded
  • SRPT 1980
  • PAYO 2005
  • Country
  • SRPT United States
  • PAYO United States
  • Employees
  • SRPT N/A
  • PAYO N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • PAYO EDP Services
  • Sector
  • SRPT Health Care
  • PAYO Technology
  • Exchange
  • SRPT Nasdaq
  • PAYO Nasdaq
  • Market Cap
  • SRPT 1.9B
  • PAYO 2.1B
  • IPO Year
  • SRPT 1997
  • PAYO N/A
  • Fundamental
  • Price
  • SRPT $23.53
  • PAYO $5.97
  • Analyst Decision
  • SRPT Hold
  • PAYO Strong Buy
  • Analyst Count
  • SRPT 31
  • PAYO 8
  • Target Price
  • SRPT $40.61
  • PAYO $10.06
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • PAYO 2.5M
  • Earning Date
  • SRPT 11-05-2025
  • PAYO 11-04-2025
  • Dividend Yield
  • SRPT N/A
  • PAYO N/A
  • EPS Growth
  • SRPT N/A
  • PAYO N/A
  • EPS
  • SRPT N/A
  • PAYO 0.25
  • Revenue
  • SRPT $2,481,531,000.00
  • PAYO $1,017,244,000.00
  • Revenue This Year
  • SRPT $9.41
  • PAYO $9.34
  • Revenue Next Year
  • SRPT N/A
  • PAYO $7.48
  • P/E Ratio
  • SRPT N/A
  • PAYO $23.12
  • Revenue Growth
  • SRPT 64.89
  • PAYO 13.02
  • 52 Week Low
  • SRPT $10.42
  • PAYO $5.66
  • 52 Week High
  • SRPT $138.81
  • PAYO $11.29
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 62.36
  • PAYO 42.64
  • Support Level
  • SRPT $21.93
  • PAYO $5.66
  • Resistance Level
  • SRPT $23.87
  • PAYO $6.01
  • Average True Range (ATR)
  • SRPT 1.42
  • PAYO 0.20
  • MACD
  • SRPT 0.10
  • PAYO -0.01
  • Stochastic Oscillator
  • SRPT 71.74
  • PAYO 48.03

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

Share on Social Networks: